Skip to search formSkip to main contentSkip to account menu

LB-46

Known as: LB 46, LB46 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1981
1981
Beta-adrenergic blockade may be hazardous in asthma and chronic obstructive lung disease. The beta-adrenergic antagonist pindolol… 
1974
1974
SUMMARY 1. Seven β‐adrenoreceptor antagonists, namely (±)‐propranolol, (—)‐propranolol, (±)‐alprenolol, pindolol (prindolol; LB46… 
1973
1973
The β-adrenoceptor antagonists LB46, oxprenolol, K01366, propranolol, and practolol all decrease the myocardial demand for oxygen… 
1973
1973
SummaryThe duration of beta-receptor blockade after single oral doses of LB-46 has been investigated by the isoproterenol… 
1972
1972
Inotropic dose-response curves were constructed for a series of beta-adrenoceptor antagonists, based on the inotropic responses… 
1971
1971
1 As a local anaesthetic on frog nerve, LB46 had 0·4 times the activity of procaine and 2 times that of INPEA. 2 In reducing the… 
1971
1971
1 In isolated perfused guinea‐pig hearts, isoprenaline (2 × 10−8 g/ml) reduced the negative chronotropic responses to vagal… 
1970
1970
4‐(2‐Hydroxy‐3‐isopropylaminopropoxy)indole (LB46) is a competitive β‐adrenoreceptor blocking drug with a potency of between 4…